U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H19N3O.C6H8O7
Molecular Weight 437.4445
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXOLAMINE CITRATE

SMILES

CCN(CC)CCc1nc(-c2ccccc2)no1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

InChI

InChIKey=RBZIGQJSMCOHSS-UHFFFAOYSA-N
InChI=1S/C14H19N3O.C6H8O7/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-9H,3-4,10-11H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

HIDE SMILES / InChI

Molecular Formula C14H19N3O
Molecular Weight 245.3207
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H8O7
Molecular Weight 192.1238
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Oxolamine under brand names Symphocal, Perebron is used in some countries as a cough suppressant for the treatment of pharyngitis, tracheitis, bronchitis, bronchiectasis, pertussis. Oxolamine possesses anti-inflammatory activity, which causes a reduction in the irritation of the nervous receptors of the respiratory tract.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Perebron

Approved Use

Unknown
Palliative
Perebron

Approved Use

Unknown
Palliative
Perebron

Approved Use

Unknown
Palliative
Perebron

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Effect of oxolamine on cough sensitivity in COPD patients.
2002 Jan
Patents

Sample Use Guides

In general, 15-25 mg per kilogram per day should be given by dividing four equal doses. In children over 2 years: 1-2 ml of 5 ml Adults: 2 ml of 5 ml 4 times daily 4 hours a day, after an equal amount of water.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Jun 25 22:05:19 UTC 2021
Edited
by admin
on Fri Jun 25 22:05:19 UTC 2021
Record UNII
K5X4XBR694
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXOLAMINE CITRATE
MART.   MI   WHO-DD  
Systematic Name English
NSC-759304
Code English
5-(2-(DIETHYLAMINO)ETHYL)-3-PHENYL-1,2,4-OXADIAZOLE CITRATE (1:1)
Systematic Name English
OXOLAMINE CITRATE [MART.]
Common Name English
FLOGOBRON
Brand Name English
BREDON
Brand Name English
BRONCATAR
Brand Name English
OXOLAMINE CITRATE [WHO-DD]
Common Name English
PRILON
Brand Name English
PEREBRON
Brand Name English
SKF-9976
Code English
AF-438
Code English
SKF 9976
Code English
OXOLAMINE CITRATE [MI]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
217-760-6
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
CAS
1949-20-8
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
PUBCHEM
16045
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
EVMPD
SUB03576MIG
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
EPA CompTox
1949-20-8
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
FDA UNII
K5X4XBR694
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
MERCK INDEX
M8313
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY Merck Index
RXCUI
59053
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY RxNorm
MESH
C008735
Created by admin on Fri Jun 25 22:05:19 UTC 2021 , Edited by admin on Fri Jun 25 22:05:19 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY